USA, Baton Rouge 
Dr. Sanjay Juneja is a triple board-certified hematologist, medical oncologist, and physician executive working at the intersection of cancer care, artificial intelligence, and clinical informatics. Widely known globally as “TheOncDoc,” he has built an audience of over 750,000 followers and 50 million views on social media by making cancer care, science, and healthcare innovation more accessible to clinicians and the public. He serves as Vice President of Clinical AI and Medical Informatics at Tempus AI, is the author of “We Need to Talk About Cancer,” and is the co-founder of TensorBlack, an educational initiative focused on helping oncology professionals understand emerging technologies shaping cancer care. He was named Targeted Oncology’s inaugural 2024 Oncology Icon and was invited to the White House’s 2023 Healthcare Leaders in Social Media Roundtable.
Current Position
- Vice President, AI and Medical Informatics, Tempus AI (October 2024 – Present)
- Oncology Specialist, Citrus Oncology (September 2025 – Present)
- Clinical Oncology Specialist, La Roche-Posay USA (May 2024 – Present)
- Editorial Board Member, AI in Precision Oncology Journal (June 2023 – Present)
- Co-Founder, TensorBlack (August 2023 – Present)
- Medical Advisor, xCures (January 2021 – Present)
- Assistant Medical Director of Hospice, The Carpenter Health Network (November 2019 – Present)
- Member and Contributing Writer, Forbes Technology Council (January 2025 – January 2026)
Education
- BS in Biology — Louisiana State University (2005–2009)
- MD — Louisiana State University School of Medicine in Shreveport (2009–2013)
- Residency in Internal Medicine — LSU Health Sciences Center, Shreveport (May 2013 – July 2016)
- Fellowship in Hematology and Medical Oncology — Feist-Weiller Cancer Center (2016–2019)
- Executive Education Certification in AI in Healthcare: Strategies and Implementation — Harvard Medical School (July 2024)
Professional Experience
- Vice President, AI and Medical Informatics, Tempus AI (October 2024 – Present), focusing on operationalizing AI in oncology and translating complex clinical data into tools that improve real-world care delivery, while maintaining an active clinical practice.
- Oncology Specialist, Citrus Oncology (September 2025 – Present).
- Clinical Oncology Specialist, La Roche-Posay USA (May 2024 – Present), providing insights on oncology clinical workflows and resources related to anti-neoplastic skin side effects, with a focus on preventative and empiric aspects of skin optimization during anti-neoplastic therapy.
- Hematologist and Medical Oncologist, Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana (January 2022 – September 2024).
- Chief of Oncology Service Line, Baton Rouge General Medical Center (July 2021 – February 2023), responsible for approving physician re-appointments, peer-to-peer review, oncology city call issues, and optimizing oncology-related workflow between physician subgroups, admitting, and inpatient pharmacy.
- Co-Founder, MedFluencers (June 2022 – January 2026), a medical and healthcare-focused agency scaled to 600+ leading social media educators in healthcare, acquired by HealthCentral in January 2026.
- Resident Teaching Faculty and Heme-Onc Site Director, BRG Internal Medicine (July 2020 – August 2024).
- Founding Partner and Chief Medical Officer of Oncology, Doctorpedia (September 2020 – January 2022).
- Chief Hematology and Oncology Clinical Fellow, Feist-Weiller Cancer Center (July 2016 – September 2019), completing a three-year fellowship in benign and malignant hematology and medical oncology.
- Member, Admissions Committee, LSUHSC School of Medicine (July 2015 – September 2019), serving as the only resident physician on the committee alongside 16 associate professors and staff.
- Executive Council President, LSU Health Sciences Center (July 2015 – June 2016), serving as President of the Executive Residency Council for all residents and fellows across all specialties.
- Teacher and Tutor, MCAT Chemistry and Physics, The Princeton Review (April 2009 – April 2011).
- His debut podcast, Target Cancer: Podcast, amassed 4 million+ downloads in over 120 countries within two years.
- His insights have been featured in The Washington Post, WIRED, Bloomberg, and PBS.
Research Activity
- Artificial intelligence and clinical informatics in oncology, with a focus on operationalizing AI in real-world care delivery.
- Reducing friction across clinical workflows and improving interoperability in healthcare systems.
- Designing systems to better support physicians in delivering high-quality care, particularly in community settings.
- Digital health, medical education, and the role of data, communication, and trust in patient outcomes and clinical decision-making.
- AI applications in precision oncology.
- Anti-neoplastic skin side effects and skin optimization during cancer therapy.
Memberships / Honors / Awards
- Targeted Oncology Inaugural 2024 Oncology Icon
- White House 2023 Healthcare Leaders in Social Media Roundtable Invitee
- 40 Under 40 Honoree
- Capital Region’s Top 500 Most Influential Leaders (three consecutive years)
- Outstanding Resident of the Year (two awards)
- Outstanding Intern of the Year
- Don and Ruby Horton Generosity of Spirit Award
- LSU Homecoming King 2008 — 2nd Place
- Member, Forbes Technology Council
- Editorial Board Member, AI in Precision Oncology Journal
- Harvard Medical School Executive Education Certification in AI in Healthcare
Areas of Specialization
- Hematology and medical oncology
- Artificial intelligence and clinical informatics in oncology
- Digital health and healthcare innovation
- Medical education and science communication
- Precision oncology
- Community oncology care
Publications
Juneja S. We Need to Talk About Cancer. Published author.
All information is sourced from publicly available materials.